New therapy uses electricity to cancel out Parkinson tremors

February 18, 2013
New therapy uses electricity to cancel out Parkinson tremors
A new therapy for Parkinson's cancels out brain signals causing the characteristic tremors.

A new therapy could help suppress tremors in people with Parkinson's disease, an Oxford University study suggests.

The technique – called transcranial alternating current stimulation or TACS – cancels out the causing the tremors by applying a small, safe electric current across electrodes on the outside of a patient's head.

The preliminary study, conducted with 15 people with Parkinson's disease at Oxford's John Radcliffe Hospital, is published in the journal . The researchers showed a 50 per cent reduction in resting tremors among the patients.

Physical tremors are a significant and debilitating symptom of Parkinson's disease, but do not respond well to existing drug treatments.

Tremors can be successfully treated with deep stimulation, a technique that involves surgery to insert electrodes deep into the brain itself to deliver . But this is expensive and carries some health risks, including bleeding in to the brain, which means it is not suitable for all patients.

In TACS in contrast, the electrode pads are placed on the outside of the patient's head, so it does not carry the risks associated with .

Professor Peter Brown of the Nuffield Department of Clinical Neurosciences, who led the study, said: 'Tremors experienced by Parkinson's sufferers can be devastating and any therapy that can suppress or reduce those tremors significantly improves quality of life for patients.

'We are very hopeful this research may, in time, lead to a therapy that is both successful and carries reduced medical risks. We have proved the principle, now we have to optimise it and adapt it so it is able to be used in patients. Often that is the hardest part.'

The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (Oxford BRC), a collaboration between Oxford University Hospitals NHS Trust and Oxford University to accelerate healthcare innovation. It was also supported by the Medical Research Council, Rosetrees Trust, the Wellcome Trust and the Engineering and Physical Sciences Research Council.

TACS works by placing two electrode pads on the patient, one close to the base of the neck and one on the head, above the motor cortex (part of the brain implicated in controlling the tremors).

The small alternating current stimulation the electrodes deliver is matched to the oscillating tremor signal to cancel it out, and suppress the physical tremor.

Professor Brown said: 'The approach is based on the fact the brain operates using brain waves. If we can stimulate with matching waves we can either replace a signal that is absent or, in this case, cancel out a pathological brain wave.

'It is similar to the principle of noise-cancelling headphones that we are all familiar with. Those headphones detect ambient noise and then produce a signal to cancel it out.'

Professor Brown said the therapy now had to be developed into a viable patient treatment for Parkinson's tremors, which could involve a system that would continually detect the brain signal and adjust the delivered stimulation to cancel it out.

He said such technology could involve a system where pads were placed under the skin, allowing the therapy to remain 'minimally invasive' to reduce risk but making it more convenient for a patient to be fitted with the device.

He added: 'There would be nothing to see, no wires on show, but it would deliver stimulation continuously.'

Professor Brown said further work would also look at the effectiveness of prolonged stimulation and whether the therapy may help the brain adapt itself to control tremors.

Explore further: Less-invasive method of brain stimulation helps patients with Parkinson's disease

Related Stories

Less-invasive method of brain stimulation helps patients with Parkinson's disease

October 16, 2012
Electrical stimulation using extradural electrodes—placed underneath the skull but not implanted in the brain—is a safe approach with meaningful benefits for patients with Parkinson's disease, reports the October issue ...

Study creates tool to track real-time chemical changes in brain

July 16, 2012
Mayo Clinic researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation (DBS). The groundbreaking insight will help physicians more effectively use ...

Most patients stop drugs for essential tremor after deep brain stimulation surgery

April 7, 2011
Deep brain stimulation, a surgical procedure to suppress faulty nerve signals, allowed 77 percent of patients to stop the medications used to treat their essential tremors within one year following the surgery, University ...

Recommended for you

Parkinson's is partly an autoimmune disease, study finds

June 21, 2017
Researchers have found the first direct evidence that autoimmunity—in which the immune system attacks the body's own tissues—plays a role in Parkinson's disease, the neurodegenerative movement disorder. The findings raise ...

Predicting cognitive deficits in people with Parkinson's disease

June 20, 2017
Parkinson's disease (PD) is commonly thought of as a movement disorder, but after years of living with PD approximately twenty five percent of patients also experience deficits in cognition that impair function. A newly developed ...

Pre-clinical study suggests Parkinson's could start in gut endocrine cells

June 15, 2017
Recent research on Parkinson's disease has focused on the gut-brain connection, examining patients' gut bacteria, and even how severing the vagus nerve connecting the stomach and brain might protect some people from the debilitating ...

Hi-res view of protein complex shows how it breaks up protein tangles

June 15, 2017
Misfolded proteins are the culprits behind amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and other neurodegenerative brain disorders. These distorted proteins are unable to perform their normal ...

CRISPR tech leads to new screening tool for Parkinson's disease

June 5, 2017
A team of researchers at the University of Central Florida is using breakthrough gene-editing technology to develop a new screening tool for Parkinson's disease, a debilitating degenerative disorder of the nervous system. ...

Infection with seasonal flu may increase risk of developing Parkinson's disease

May 30, 2017
Most cases of Parkinson's have no known cause, and researchers continue to debate and study possible factors that may contribute to the disease. Research reported in the journal npj Parkinson's Disease suggests that a certain ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.